Following a September 2009 announcement regarding plans for an initial public offering, Russia’s Human Stem Cell Institute (HSCI) has become the first Russian company to hold an IPO in over a year. The USD 4.6 million offering was made via the MICEX Stock Exchange, in the Innovation and Growth Companies sector. 15 million shares were [...]

Human Stem Cell Institute (HSCI), the Russian biotechnology company owned by Artur & Andrey Isaev and Alexander Prikhodko, has announced plans to offer an IPO to be listed on the MICEX Stock Exchange. The planned USD 5 million offering will be 15% to 25% of total HSCI shares and will be conducted later this year. [...]